As early as April 2020 during the onset of the COVID pandemic, Providence’s personal Call-to-Action had us utilize our expert knowledge and resources on mRNA, to create a Best-In-Class COVID-19 vaccine.
Over the course of the last several months, Providence has consistently delivered the message that with mRNA Biotechnology right here in Canada, we are in a good position to provide a Canadian-made mRNA Covid-19 Vaccine Solution that will help restore safety and economic stability to the lives of Canadians and global citizens.
PROVIDENCE’S CALL-TO-ACTION FOR CANADIAN MADE mRNA VACCINE
Press Conference - February 5th, 2021
Brad Sorenson, CEO of Providence, Addressing Canada’s Federal Government’s Lack of domestic Biotech support, and Accountability.
"The Federal Government has been abysmal on this file"Sept 13th, 2021